As of Aug 18
| +0.11 / +0.47%|
The 4 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 49.00, with a high estimate of 85.00 and a low estimate of 35.00. The median estimate represents a +108.16% increase from the last price of 23.54.
The current consensus among 4 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.